S-1
XBRL
FORM S-1
- Company
- Immunovant, Inc.
- Filed
- August 31, 2020
- Accession Number
- 0001193125-20-235301
An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →